{"id":46347,"date":"2022-07-19T20:01:59","date_gmt":"2022-07-19T18:01:59","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/cosan-and-genomind-partner-to-help-prevent-adverse-prescription-drug-events-for-older-adults\/"},"modified":"2022-07-19T20:01:59","modified_gmt":"2022-07-19T18:01:59","slug":"cosan-and-genomind-partner-to-help-prevent-adverse-prescription-drug-events-for-older-adults","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/cosan-and-genomind-partner-to-help-prevent-adverse-prescription-drug-events-for-older-adults\/","title":{"rendered":"Cos\u00e1n and Genomind Partner to Help Prevent Adverse Prescription Drug Events for Older Adults"},"content":{"rendered":"
\n

\nIntegrated precision medication management platform empowers clinicians with genetic insights intended to reduce polypharmacy errors that cost thousands of lives and billions of dollars annually<\/i>\n<\/p>\n

MOORESTOWN, N.J.–(BUSINESS WIRE)–Cos\u00e1n<\/a>, a provider of technology-driven preventative care services for older adults and the physicians that support them, and Genomind<\/a>, a leading precision healthcare company, have partnered to fill an existing gap in aging adult care management by providing Cos\u00e1n\u2019s network of physicians with Genomind\u2019s integrated precision medication management platform. The platform will provide insights that will help Cos\u00e1n to achieve the best outcomes for their patient population, prevent adverse drug events and reduce avoidable costs of medication mismanagement.\n<\/p>\n

<\/a><\/p>\n

\nWith over 40%<\/a> of U.S. adults 65 years of age and older taking five or more prescription medicines, aging populations are at high-risk for adverse drug events. Through this partnership, Genomind\u2019s analytic capabilities will provide Cos\u00e1n with risk stratification insights, enabling Cos\u00e1n clinicians to target individuals that are most likely to benefit from medication reviews and pharmacogenetic (PGx) testing, also known as drug-gene testing. Genomind\u2019s PGx test adds a layer of precision medicine that leverages genetics to help providers select appropriate medications and dosing. Equipped with advanced pharmacogenetic screening, clinical concierge services and access to expert pharmacists, Cos\u00e1n\u2019s care teams can then incorporate individualized insights into each patient\u2019s chronic care management plan so medications are administered safely.\n<\/p>\n

\n\u201cThis partnership brings a new level of pharmacy and genetic expertise to the thousands of providers and the patients they support, marking yet another stride in the delivery of effective preventative care management services,\u201d said David Hunt, Founder & President at Cos\u00e1n. \u201cThese unique drug analytic and genetic testing capabilities provide Cos\u00e1n\u2019s network of physicians and care coordinators with another tool designed to help eliminate avoidable drug risks and improve overall care quality for vulnerable patients receiving care from their homes.\u201d\n<\/p>\n

\nAccording to the CDC<\/a>, adverse drug events cause approximately 1.3 million emergency department visits each year, and older adults are nearly seven times more likely to end up hospitalized after such events than younger persons. Many of these adverse events are caused by just a few drugs. This new platform will help physicians develop personalized therapeutic approaches for patients based on their individual genetic makeup and are designed to improve patient and physician satisfaction and reduce medical expenses. With the recent expansions by Medicare to cover PGx testing in certain circumstances, this population is particularly suited to dramatically benefit from this platform.\n<\/p>\n

\n\u201cThe prevalence and cost of medication mismanagement is unacceptable, costing thousands of lives and billions of dollars annually. We\u2019re thrilled to join Cos\u00e1n in helping to improve care management for older adults, who are at high risk for these adverse drug events,\u201d said Cynthia Kilroy, Co-CEO, Genomind.\n<\/p>\n

\nThe Cos\u00e1n\/Genomind platform is currently in the pilot testing stage and is expected to become widely implemented this year.\n<\/p>\n

\nAbout Cos\u00e1n Group
\n
<\/b>Cos\u00e1n Group, established in 2015, is an industry-leading healthcare organization creating new pathways to modern aging with technology-driven preventative care services, offering concierge home care for older adults. Early market exposure in the delivery of technology and services to support the Chronic Care Management (CCM) program, and Behavioral Health Integration (BHI) programs with Remote Patient Monitoring (RPM) has propelled Cos\u00e1n to deliver a practice and patient-centric approach to remote care coordination. Visit our website: www.cosangroup.com<\/a>\n<\/p>\n

\nAbout Genomind
\n
<\/b>Genomind is a leading precision health company focused on optimizing the treatment experience for individuals and healthcare providers through actionable genetic insights and innovative health technology. Genomind\u2019s platform integrates precision health technology and pharmacogenetic testing on an individual and population level beyond mental health. Built on the foundation of compassionate care and clinical expertise, Genomind is empowering a more targeted and personalized approach to medication management and supporting providers in a new standard of care. Learn more at http:\/\/www.genomind.com<\/a>.\n<\/p>\n

Contacts<\/b> <\/p>\n

\nCos\u00e1n Group<\/b>
Clinical inquiries: Desiree Martin \u2013 Vice President-Clinical Operations
\n
desiree.martin@cosangroup.com<\/a><\/p>\n

Business Inquiries: Michael Knipper \u2013 Vice President, Sales & Strategic Partnerships
\n
michael.knipper@cosangroup.com<\/a><\/p>\n

Press: Garth Cabral \u2013 Director of Marketing & Brand Management
\n
garth.cabral@cosangroup.com<\/a><\/p>\n

Genomind<\/b>
Clinical inquiries: David Krause, MD \u2013 Co-Chief Executive Officer
\n
dkrause@genomind.com<\/a><\/p>\n

Business inquiries: Cynthia Kilroy \u2013 Co-Chief Executive Officer
\n
ckilroy@genomind.com<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

Integrated precision medication management platform empowers clinicians with genetic insights intended to reduce polypharmacy errors that cost thousands of lives and billions of dollars annually MOORESTOWN, N.J.–(BUSINESS WIRE)–Cos\u00e1n, a provider of technology-driven preventative care services for older adults and the physicians that support them, and Genomind, a leading precision healthcare company, have partnered to fill … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":["entry","post","publish","author-business","post-46347","format-standard","category-industry"],"yoast_head":"\nCos\u00e1n and Genomind Partner to Help Prevent Adverse Prescription Drug Events for Older Adults - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/cosan-and-genomind-partner-to-help-prevent-adverse-prescription-drug-events-for-older-adults\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Cos\u00e1n and Genomind Partner to Help Prevent Adverse Prescription Drug Events for Older Adults - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"Integrated precision medication management platform empowers clinicians with genetic insights intended to reduce polypharmacy errors that cost thousands of lives and billions of dollars annually MOORESTOWN, N.J.–(BUSINESS WIRE)–Cos\u00e1n, a provider of technology-driven preventative care services for older adults and the physicians that support them, and Genomind, a leading precision healthcare company, have partnered to fill ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/cosan-and-genomind-partner-to-help-prevent-adverse-prescription-drug-events-for-older-adults\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-07-19T18:01:59+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20220719006007\/en\/1517786\/21\/Image_CosanGenomind_1287x922.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/cosan-and-genomind-partner-to-help-prevent-adverse-prescription-drug-events-for-older-adults\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/cosan-and-genomind-partner-to-help-prevent-adverse-prescription-drug-events-for-older-adults\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Cos\u00e1n and Genomind Partner to Help Prevent Adverse Prescription Drug Events for Older Adults\",\"datePublished\":\"2022-07-19T18:01:59+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/cosan-and-genomind-partner-to-help-prevent-adverse-prescription-drug-events-for-older-adults\\\/\"},\"wordCount\":738,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/cosan-and-genomind-partner-to-help-prevent-adverse-prescription-drug-events-for-older-adults\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220719006007\\\/en\\\/1517786\\\/21\\\/Image_CosanGenomind_1287x922.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/cosan-and-genomind-partner-to-help-prevent-adverse-prescription-drug-events-for-older-adults\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/cosan-and-genomind-partner-to-help-prevent-adverse-prescription-drug-events-for-older-adults\\\/\",\"name\":\"Cos\u00e1n and Genomind Partner to Help Prevent Adverse Prescription Drug Events for Older Adults - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/cosan-and-genomind-partner-to-help-prevent-adverse-prescription-drug-events-for-older-adults\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/cosan-and-genomind-partner-to-help-prevent-adverse-prescription-drug-events-for-older-adults\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220719006007\\\/en\\\/1517786\\\/21\\\/Image_CosanGenomind_1287x922.jpg\",\"datePublished\":\"2022-07-19T18:01:59+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/cosan-and-genomind-partner-to-help-prevent-adverse-prescription-drug-events-for-older-adults\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/cosan-and-genomind-partner-to-help-prevent-adverse-prescription-drug-events-for-older-adults\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/cosan-and-genomind-partner-to-help-prevent-adverse-prescription-drug-events-for-older-adults\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220719006007\\\/en\\\/1517786\\\/21\\\/Image_CosanGenomind_1287x922.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220719006007\\\/en\\\/1517786\\\/21\\\/Image_CosanGenomind_1287x922.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/cosan-and-genomind-partner-to-help-prevent-adverse-prescription-drug-events-for-older-adults\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Cos\u00e1n and Genomind Partner to Help Prevent Adverse Prescription Drug Events for Older Adults\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Cos\u00e1n and Genomind Partner to Help Prevent Adverse Prescription Drug Events for Older Adults - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/cosan-and-genomind-partner-to-help-prevent-adverse-prescription-drug-events-for-older-adults\/","og_locale":"en_US","og_type":"article","og_title":"Cos\u00e1n and Genomind Partner to Help Prevent Adverse Prescription Drug Events for Older Adults - Pharma Trend","og_description":"Integrated precision medication management platform empowers clinicians with genetic insights intended to reduce polypharmacy errors that cost thousands of lives and billions of dollars annually MOORESTOWN, N.J.–(BUSINESS WIRE)–Cos\u00e1n, a provider of technology-driven preventative care services for older adults and the physicians that support them, and Genomind, a leading precision healthcare company, have partnered to fill ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/cosan-and-genomind-partner-to-help-prevent-adverse-prescription-drug-events-for-older-adults\/","og_site_name":"Pharma Trend","article_published_time":"2022-07-19T18:01:59+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20220719006007\/en\/1517786\/21\/Image_CosanGenomind_1287x922.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/cosan-and-genomind-partner-to-help-prevent-adverse-prescription-drug-events-for-older-adults\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/cosan-and-genomind-partner-to-help-prevent-adverse-prescription-drug-events-for-older-adults\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Cos\u00e1n and Genomind Partner to Help Prevent Adverse Prescription Drug Events for Older Adults","datePublished":"2022-07-19T18:01:59+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/cosan-and-genomind-partner-to-help-prevent-adverse-prescription-drug-events-for-older-adults\/"},"wordCount":738,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/cosan-and-genomind-partner-to-help-prevent-adverse-prescription-drug-events-for-older-adults\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220719006007\/en\/1517786\/21\/Image_CosanGenomind_1287x922.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/cosan-and-genomind-partner-to-help-prevent-adverse-prescription-drug-events-for-older-adults\/","url":"https:\/\/pharma-trend.com\/en\/cosan-and-genomind-partner-to-help-prevent-adverse-prescription-drug-events-for-older-adults\/","name":"Cos\u00e1n and Genomind Partner to Help Prevent Adverse Prescription Drug Events for Older Adults - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/cosan-and-genomind-partner-to-help-prevent-adverse-prescription-drug-events-for-older-adults\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/cosan-and-genomind-partner-to-help-prevent-adverse-prescription-drug-events-for-older-adults\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220719006007\/en\/1517786\/21\/Image_CosanGenomind_1287x922.jpg","datePublished":"2022-07-19T18:01:59+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/cosan-and-genomind-partner-to-help-prevent-adverse-prescription-drug-events-for-older-adults\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/cosan-and-genomind-partner-to-help-prevent-adverse-prescription-drug-events-for-older-adults\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/cosan-and-genomind-partner-to-help-prevent-adverse-prescription-drug-events-for-older-adults\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20220719006007\/en\/1517786\/21\/Image_CosanGenomind_1287x922.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20220719006007\/en\/1517786\/21\/Image_CosanGenomind_1287x922.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/cosan-and-genomind-partner-to-help-prevent-adverse-prescription-drug-events-for-older-adults\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Cos\u00e1n and Genomind Partner to Help Prevent Adverse Prescription Drug Events for Older Adults"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/46347","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=46347"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/46347\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=46347"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=46347"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=46347"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}